Workflow
Standard Uranium Closes Second Tranche of Private Placement and Announces LIFE Offering
aTyr PharmaaTyr Pharma(US:LIFE) Newsfileยท2025-09-24 11:30

Core Viewpoint - Standard Uranium Ltd. has successfully closed the second tranche of its non-brokered private placement, raising gross proceeds of $484,000, and is planning a LIFE Offering to further enhance its capital for exploration projects [2][5][6]. Private Placement Offering - The second tranche involved the issuance of 1,550,000 non-flow-through units at $0.08 each, generating $124,000, and 3,600,000 flow-through units at $0.10 each, generating $360,000 [3]. - The total gross proceeds from both tranches of the Private Placement Offering amount to $1,320,100, with a total of 9,301,250 non-flow-through units and 5,760,000 flow-through units issued [5]. - The company plans to raise a total of $3,500,000 through the completion of additional tranches, with the final tranche expected to close before October 31, 2025 [5][9]. LIFE Offering - The company will offer up to 20,000,000 flow-through units under the Listed Issuer Financing Exemption, which will not be subject to a hold period [6]. - The net proceeds from both the Private Placement Offering and the LIFE Offering are intended for exploration of the company's uranium projects in Saskatchewan and for working capital purposes [8]. Company Overview - Standard Uranium is focused on uranium exploration in the Athabasca Basin, holding interests in over 233,455 acres (94,476 hectares) [10]. - The company's Davidson River Project is highly prospective for basement-hosted uranium deposits, with significant confidence in its exploration model due to recent drilling results [11]. - The eastern Athabasca projects and the Sun Dog project also show high potential for uranium deposits based on historical occurrences and geophysical anomalies [12][13].